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Despi te quantum improvements in drug efficacy in recent decades, the effect of existing therapeutic options for osteoporosis remains modest. Although pharmaceutical interventions have been shown to improve bone mass and decrease the incidence of fragility fracture, these improvements are not observed in all patients; some individuals suffer unacceptable side effects, and compliance is poor. 1, 2 Perhaps even more significantly, a majority of hip fractures occur as a direct result of a fall. Medications that improve bone mass do not generally influence neuromuscular performance 3 and thus offer no protection from falls. To reduce falls, lower limb muscle strength and balance must be addressed. 4 Although lifelong exercise is thought to optimize bone mass and neuromuscular function, for most, the intensity of exercise loading that can be tolerated in old age is unlikely to provide an adequate stimulus to notably improve bone. Moreover, despite the known systemic benefits of exercise, many people remain reluctant or unable to incorporate regular physical activity into their daily life. 5 The reluctance is particularly evident for those aged 65 years and older, 6 that is, those most at risk of hip fracture. However, evidence is mounting that passive exposure to low-intensity mechanical loading may be osteogenic if applied at sufficiently high frequency; for example, via whole body vibration (WBV). 7, 8 It has been observed that ϳ80% of a 30-Hz vibration stimulus at the feet during standing can be transmitted to clinically relevant bony sites (hip and spine). 9 WBV may also improve muscle strength and balance and thus has the potential to not only enhance bone health but also prevent falls. 10 Previous trials have predominantly examined the effect of WBV on most, if not all, days of the week. Considering the known challenges of patient compliance with most forms of treatment, determining the minimum effective dose of WBV is of critical therapeutic significance. The therapeutic dose of WBV with real-life acceptability to populations at risk of hip fracture may be as few as one to two exposures per week.
The number of commercially available WBV devices has increased markedly in recent years. Where once the primary target market for vibration was the fitness industry, claims of clinical applications beyond the research evidence are now routinely advertised. The fact that substantial differences in stimulus intensity exist between the range of WBV devices is largely unrecognized or unacknowledged by the industry. In reality, evidence exists to suggest that cells can distinguish between different vibration frequencies and amplitudes, 11, 12 such that the findings of studies examining effects of one WBV device cannot automatically be applied to another that operates at a different vibration intensity. It is of additional concern that many WBV devices operate at intensities beyond the safety limits described by the International Organization for Standardization (ISO 2631/3).
The aim of this project was to determine and compare the effects of 8 mos of twice-weekly, brief, low-intensity WBV (0.3 g acceleration) vs. relatively high-intensity WBV (1 g acceleration) on risk factors for hip fracture (bone strength parameters, muscle function and balance) in independently living postmenopausal women. We hypothesized that (1) 8 mos of twice-weekly WBV would improve bone and muscle strength and balance; (2) differences would be observed between effects of lowand higher intensity WBV; and (3) treatment effects would be related to age, height, weight, initial bone mass, current physical activity, dietary calcium, and compliance.
METHODS

Ethical Approval
All study activities were undertaken with the understanding and written consent of each subject, with the approval of the Griffith University Human Research Ethics Committee and in accordance with the Code of Ethical Principles for Medical Research Involving Human Subjects of the World Medical Association (Declaration of Helsinki).
Study Design and Location
An 8-mo randomized controlled intervention trial was conducted. We chose an 8-mo study duration to optimize our ability to detect changes in bone, while minimizing the risk of subject dropout that tends to increase with study duration. Supervised vibration sessions occurred twice-weekly at a local retirement village. Testing was completed at the Bone Densitometry Research Laboratory, Griffith University.
Subject Recruiting and Sample Size
Recruiting flyers were posted in many locations frequented by our target cohort, including shopping centers and seniors clubs. Advertisements were placed in local newspapers and community newsletters. We also distributed flyers at retirement villages and ultimately based the study intervention at the retirement village from which we had the greatest recruiting response. Just under half of the participants resided in independent dwellings at the retirement village, with the remainder living in the wider community.
Women Ͼ5 yrs past menopause were enrolled to avoid the confounding effects of accelerated bone loss in the immediate postmenopausal years.
Postmenopausal status was defined as the absence of menstruation for Ն12 mos, either after the age of 55 yrs or after bilateral oophorectomy. Subjects were included if they were of sound general physical and cognitive health, fully ambulatory, and able to commit to twice-weekly participation for 8 mos. Subjects were excluded from the study if they had a metabolic bone disease, endocrine disorder, or chronic renal pathology; had begun taking medications known to effect bone (including hormone therapy, bisphosphonates, parathyroid hormone, etc.) in the previous 12 mos; or were recovering from lower limb fracture or other immobilizing injury.
To obtain sufficient statistical power to detect an effect in all dependent variables, we calculated the sample size required for the measure with the smallest expected effect size (i.e., bone mineral density [BMD] ). Studies of exercise interventions for bone in elderly cohorts commonly observe a rate of ϳ1% bone loss in control groups over 12 months. 13 To detect a 1% BMD difference with 0.8% SD, at an alpha of 0.05, for 80% power, 11 subjects were required in each group. A standard deviation of 0.8% is modest but commensurate with previous reports.
14 A minimum of four additional subjects were recruited into each group to accommodate potential attrition. True observed power is reported in the Results section as 1-␤ after each statistically significant finding. Observed power averaged 70% for significant bone effects and 83% for muscle effects.
Randomization
The randomization scheme was generated using the first generator on the website Randomization.com (http://www.randomization.com; Dallal, 2007) for a three-group trial. Subjects were assigned to the randomization scheme in the order of recruitment.
Testing
Age, height, weight, bone, muscle, and balance parameters were measured at baseline and follow-up (8 mos) as described below, by assessors blind to group allocation. Behavioral characteristics relevant to bone status, including dietary calcium and physical activity, were recorded via questionnaire.
Biometrics
Subject height was measured to the nearest millimeter using a stadiometer (HART Sport & Leisure, Australia). Weight was measured using digital scales (Soehnle Co., Switzerland) to the nearest 0.1 kg. Lean tissue and fat mass were obtained from whole body (WB) scans using an XR-36 Quickscan dual-energy x-ray absorptiometer (DXA) (Norland Medical Systems, Inc.) with host software, version 3.9.4, and scanner software version 2.0.0.
Bone Parameters
The 8-mo duration of the study was chosen as a time period during which changes in bone mass and size can be detected from DXA. DXA-derived bone area, bone mineral content (BMC) and BMD of the WB, nondominant femoral neck (FN), trochanter, lumbar spine (LS), and proximal forearm (PFA) were examined. FN cross-sectional moment of inertia was calculated from DXA measures using the methods of Sievanen et al., 15 to derive an approximation of bending strength.
Quantitative ultrasonometry of the heel (QUS-2 Ultrasound Densitometer; Quidel Corporation, CA) was used to determine broadband ultrasound attenuation (BUA) of the nondominant calcaneus. Calcaneal dominance was determined as the side with which a subject would kick a ball.
One investigator (B.B.) performed all bone measures. The coefficients of variation for BMD measures were as follows: WB, 0.8%; LS, 1.2%; FN, 1.4%; and PFA, 0.7%.
Muscle Function
The wall squat and chair rise tests were used to examine muscle performance. These functional tests were selected for their simplicity and relevance to a daily task often associated with falling (lowering the body from standing). During the wall squat test, subjects stood comfortably on both feet, with their back against a smooth wall. They then slid their back down the wall until a 90-degree angle at the hip and knee was achieved. One foot was lifted off the ground during which the stopwatch was started. The watch was stopped when subjects had to return the raised foot to the ground. Both limbs were tested, and measures were taken in seconds. For the chair rise test, 16 the time to rise from and sit back down into a minimally padded straight-backed chair five times with arms folded was recorded in seconds. One investigator (T.N.) performed all muscle measures.
Balance
Static balance was measured using the single leg stance test. The length of time a subject could stand on their preferred limb without notable perturbation per the traditional protocol 17 was measured in seconds. Dynamic balance was measured in seconds by using the tandem walk test (walking heel-to-toe on a straight line for 6 m). 16 One investigator (T.N.) performed all balance measures.
Physical Activity
A score of physical activity relevant to bone loading history was derived for each subject, from www.ajpmr.com
Whole Body Vibration and Hip Fracture responses to a bone-specific physical activity questionnaire, as previously described 18 and available online (http://www.fithdysign.com/BPAQ).
Calcium Consumption
Dietary calcium was derived from responses to a calcium-focused, customized Australian food questionnaire. Subjects were asked to indicate the type and amount of each food item consumed on average over a period of 1 day, 1 wk, or 1 mo. The average daily intake of dietary calcium was then determined using Foodworks (version 5; Xyris Software Pty Ltd., Brisbane, Australia).
Group Activities Control Group
Participants randomly allocated to the control group (group 1) took part in baseline testing and were then instructed to continue regular daily activities (and abstain from WBV) for a period of 8 mos before attending follow-up testing. All subjects were issued diaries in which they were asked to record falls, fractures, changes in diet, medications, and physical activity. Subjects were asked to avoid changing patterns of physical activity during the study period.
Intervention Groups
Participants randomly allocated to the intervention groups were tested, and then they attended two sessions of supervised standing WBV twice a week for 8 mos before follow-up testing. The low-intensity WBV (LWBV) device (Juvent 1000 DMT, Somerset, NJ) is a flat, low set, relatively small platform providing a very mild vertical perturbation (Fig. 1) . The loading parameters of the LWBV device were manufacturer settings of 0.3 g peak-to-peak acceleration at 30 Hz (root mean square power averaging 0.106 m⅐sec Ϫ2 ). Group 2 participants stood for 15 mins in full extension on the LWBV device from the first session. The higher intensity WBV (HWBV) device (Galileo2000, Novotec Maschinen GmbH, Pforzheim, Germany) was larger, higher set, and comprised a platform that oscillated around a sagittal axis at an amplitude of 0 -14 mm, depending on foot position. With feet shoulder-width apart, the stimulus amplitude was ϳ2 mm. At an oscillation frequency of 12.5 Hz, the stimulus acceleration was ϳ1 g (root mean square power averaging 0.52 m⅐sec
Ϫ2
). Group 3 participants stood with knees slightly bent for two bouts of 3 mins separated by a one-min rest. The length of individual vibration bouts was progressively increased from 1 to 3 mins over the initial 2 wks. A single investigator (T.N.) supervised all intervention sessions, monitoring form and compliance.
The slight differences in intervention protocols reflect the fundamentally different theoretical premises from which high-and low-intensity WBV technologies were developed. The LWBV device was developed from animal studies that indicated that very low strains applied to bone around 30 Hz are most osteogenic. 7, 8 HWBV devices were originally developed to potentiate muscle training effects. 19 The idea that HWBV will enhance bone is based on the notion that bone adapts as a function of muscle loading (or overloading) rather than a direct effect of vibration on the bone itself. It was important for reasons of practical translation to adopt WBV protocols around which each WBV technology was developed.
Statistical Analyses
Repeated-measures analysis of covariance with adjustments for multiple comparisons was used to examine between-and within-group differences in intention-to-treat and per protocol analyses with a significance level of P Ͻ 0.05. Per protocol analysis excluded lost to follow-up and noncompliant subjects. Height, weight, age, baseline FN BMD, compliance, current physical activity, and daily calcium consumption were controlled in analyses of bone parameters to account for their known influences on the skeleton. Age, compliance, and current physical activity were controlled in muscle and balance analyses.
Stepwise multiple regression analysis was used to investigate the influence of group, compliance, age, percent change in weight, baseline values, current physical activity, percent change in lean mass, and daily calcium consumption on percent change of all bone parameters. Age, group, compliance, baseline values, and current physical activity were entered into the model for muscle and balance regression analyses.
All statistical analyses were performed using SPSS version 17.0 for Windows (SPSS, Chicago, IL).
RESULTS
Subject Characteristics
Forty-seven women (mean age, 71.5 Ϯ 9.0 yrs) who were eligible for the study were consented and randomized into one of three groups; control (n ϭ 15), LWBV (n ϭ 15), and HWBV (n ϭ 17) (Fig. 2. ) Four subjects were lost to follow-up, and one subject was excluded for failing to comply with the protocol. Of these, two were lost from the HWBV group (one with dementia and one with pelvic fracture), one from the LWBV group (shingles), and one from the control group (declined follow-up testing). The subject excluded for noncompliance reported initiating and ceasing a number of bone medications during the course of the trial. Baseline group characteristics are presented in Table 1 . The mean whole group FN BMD T-score at baseline of Ϫ2.2 Ϯ 1.1 (range, Ϫ4.18 -0.6) and Z-score of 0.17 Ϯ 1.1 (range, Ϫ1.55-2.94) from the intentionto-treat analysis revealed that the cohort exhibited bone mass in the normal range for age. As findings from the intention-to-treat and per protocol analyses were similar, we report per protocol data to reflect findings directly related to intervention exposure.
Groups did not differ significantly in age and anthropometric or behavioral characteristics at baseline, with the exception of weight, which was 
Compliance
Treatment compliance was 92.1% for LWBV participants and 91% for the HWBV group. Examination of study diaries at follow-up confirmed all subjects had complied with the request to maintain stable patterns of extraneous physical activity over the course of the trial.
Falls
Our study was not powered to detect a treatment effect on falls; however, we note that three subjects in the LWBV group, one in the HWBV group, and six in the control group fell once during the course of the trial.
Treatment Effects Biometrics
There were no between-or within-group treatment effects on weight, height, body mass index, percent fat, or lean mass.
Bone
Repeated-measures analysis of covariance controlling for age, height, weight, daily calcium consumption, compliance, and baseline FN BMD found no between-group differences in any outcome measure; however, a number of within-group effects were observed. As a within-group analysis involves the examination of change in the same subjects from baseline to follow-up, the focus for this secondary analysis was on BMC rather than BMD as a more representative indicator of total bone mass at each site. Significant within-group effects indicated that controls lost trochanteric BMC (Ϫ6.0%, P ϭ 0.03, 1-␤ ϭ 0.60), spine (LS) BMC (Ϫ6.6%, P ϭ 0.02, 1-␤ ϭ 0.65) and LS area (Ϫ5.7%, P ϭ 0.0009, 1-␤ ϭ 0.76), whereas vibration groups did not. LWBV subjects increased FN area (2.3%, P ϭ 0.02, 1-␤ ϭ 0.60). A significant increase in HWBV subjects' calcaneal BUA (3.4%, P ϭ 0.05, 1-␤ ϭ 0.50) was also observed; however, power was low. Despite no observed loss at the hip or spine, the LWBV group lost WB BMC (2.1%, P ϭ 0.03, 1-␤ ϭ 0.70) and PFA BMD (1.4%, P ϭ 0.005, 1-␤ ϭ 0.86) ( Table 2 ; Fig. 3) .
Multiple regression analyses revealed only a modest ability of any independent variable to predict percent change in dependent bone variables. Percent change in lean mass accounted for 21% and 16% of the variance associated with percent change in WB BMC (P ϭ 0.003) and WB BMD (P ϭ 0.01), respectively; and group allocation accounted for 10% and 14% of the variance associated with percent change in LS BMC (P ϭ 0.04) and area (P ϭ 0.02), respectively.
Muscle
No between-group differences were revealed for any muscle measure; however, within-group effects were again observed. Wall squat time improved significantly for the vibration groups but not the control group at the dominant leg (HWBV, 70.9%, P ϭ 0.02, 1-␤ ϭ 0.80) and nondominant leg (HWBV, 119.5%, P ϭ 0.004, 1-␤ ϭ 0.85; LWBV, 70.1%, P ϭ 0.03, 1-␤ ϭ 0.65). Chair rise time also improved significantly in the vibration groups only (HWBV, Ϫ10.1%, P Ͻ 0.05, 1-␤ ϭ 0.55; LWBV, Ϫ11.5%, P ϭ 0.05, 1-␤ ϭ 0.50), although power was low (Table 2 ; Fig. 4) . No independent variable was significantly associated with percent change in wall squat or chair rise time in the regression analysis.
Balance
No whole group, between-group, or withingroup effects were evident for tandem walk or single leg stance time (Table 2 ; Fig. 4 ). There were no significant predictors of single leg stance time, but baseline tandem walk time predicted 11.6% of the variance in percent change in tandem walk (P ϭ 0.03).
DISCUSSION
Our goal was to determine the effect of two sessions per week of brief, low-intensity or higher intensity WBV for 8 mos on risk factors for hip fracture in independently living postmenopausal women. To our knowledge, there has been no previous comparison made between vibration intensi- Table 2 . Although recognized as a less meaningful finding than a true between-group treatment effect, within-group effects can sometimes detect subtle findings that may be clinically significant, such as a reduction in loss rather than a gain. This effect is particularly evident in Figure 3 . Specifically, we found that control subjects lost significant trochanteric BMC (Ϫ6.0%), spine BMC (Ϫ6.6%), and spine area (Ϫ5.7%) while vibration groups did not. The changes exceed the coefficients of variation for each of these measures for our laboratory, which are 3.1%, 1.7%, and 1.4%, respectively, indicating that changes of these magnitudes are unlikely to be due to DXA measurement error. The vibration group subjects (particularly HWBV) also exhibited significant improvement in muscle endurance (wall squat) while controls did not. An analysis comparing a combined vibration group (LWBV ϩ HWBV) against controls produced similar findings for all variables.
FIGURE 3 Eight-mo within-group percent change (mean Ϯ SE) in selected bone parameters after twice-weekly whole body vibration; per protocol analysis (n ϭ 42). HWBV, higher intensity whole body vibration
Curiously, LWBV subjects lost 2.1% WB BMC and 1.4% PFA BMD during the course of the 8-mo trial. It could be surmised from this bone loss observed at the PFA (a cortical bone site not loaded by a standing vibration stimulus) and at the WB (also predominantly cortical bone) that systemic bone loss unrelated to the vibration intervention was occurring more rapidly in the LWBV than the HWBV or control groups, during the course of our study. Importantly, the LWBV group did not lose significant bone at the hip and spine (indeed a slight increase occurred in FN area), suggesting that the vibration stimulus ameliorated the effects of systemic bone loss at sites most directly exposed to the stimulus.
The nonsignificant trend for an increase in trochanteric BMC in the HWBV group may reflect hip extensor loading of the trochanter during HWBV to resist the cyclical passive flexion perturbation of the lower limb during the up phase of the oscillating plate motion. As it is well recognized that reductions in bone size can result in loss of bone strength, maintenance of LS bone area in both WBV groups can be considered advantageous in comparison with the loss observed in the control group. A significant increase in FN bone area in the LWBV group contributed to a 7.4% positive trend (P ϭ 0.09) in FN cross-sectional moment of inertia affirming the potential strength benefits of increased bone size even in the absence of improvement in BMC or BMD.
Observations at the calcaneus are consistent with the different stimuli to which subjects were exposed; that is, controls (no vibration) tended to lose 3.4% BUA (NS), LWBV subjects (who experienced no ankle perturbation) exhibited essentially no BUA change, and HWBV subjects increased BUA by 3.1% (P ϭ 0.05). Although power in the BUA analysis was low, if the improvement was real, it is likely a reflection of the repetitive calf muscle loading of the calcaneus via the Achilles tendon as a consequence of the requirement to resist cyclical passive ankle dorsi flexion during oscillating HWBV.
Notably, we did not observe a difference in effect between the two different WBV stimulus intensities. It is possible that the stimuli perceived at the level of the bones were not, in fact, different www.ajpmr.com Whole Body Vibration and Hip Fracture enough to engender a markedly different response. That is, although the HWBV perturbation was considerably higher than the LWBV at the level of the plate, with the introduction of a flexed joint stance, the stimulus was likely attenuated-potentially to the extent that the HWBV stimulus perceived at the hip and spine was similar to that of the LWBV. It is also possible that bone cells become desensitized at a certain threshold, such that more (i.e., higher WBV intensity) is not necessarily better. Five somewhat comparable, randomized trials have examined LWBV or HWBV treatment effects on bone outcomes in postmenopausal cohorts. Findings from the lone LWBV trial (same device as the present study; peak-to-peak acceleration of 0.3 g) mirrored our observations. That is, there was no observed treatment effect of LWBV; however, within-group effects were apparent for the most compliant, lightweight subjects. In that cohort, BMD losses at the hip and spine in controls were ameliorated by 12 mos of 2 ϫ 10 mins/day LWBV. 20 Three of the four HWBV trials are not entirely comparable with this study, as two included exercise during vibration and one used walking as a control. Six months of 10 mins, 30 Hz, 5-mm amplitude vibration five times per week improved FN and LS BMD in postmenopausal women with osteoporosis. 21 Although not clear from the description of the data analysis, it seems that these differences were changes within group rather than treatment effects. Six months of static and dynamic knee extensor exercises for up to 30 mins in addition to 35-40 Hz and 2.5 mm amplitude vibration (peak acceleration of up to 5 g) improved hip BMD in comparison with resistance training alone or control. 22 Eight months of 6 ϫ 1-min vibration, 3 ϫ a week at 12.6 Hz, and 3 mm amplitude (in 60 degrees of knee flexion) improved FN (but not spine) BMD and balance in comparison with walking. 23 Eighteen months of twice-weekly 25-35 Hz, 1.7 mm amplitude vibration superimposed on 15 mins of dynamic leg strength training did not effect greater changes in bone mass than the exercise training alone. 24 A systematic review of the evidence for effects of vibration on muscle strength concluded that there is moderate to strong evidence that long-term vibration exercise improves lower limb muscle performance in older cohorts, 10 which our results tend to support. A large well controlled 12-mo trial found that HWBV ϩ fitness training was associated with reduced sway in response to stance perturbation in healthy older adults (mean age, 66 yrs) but was otherwise comparable with fitness training alone. 25 Other reports indicate that HWBV, with and without exercise, has variously improved balance and stability in nursing home residents 26 and elderly community dwellers. 22 Although positive trends exist in our data, particularly for the HWBV group who exhibited a tendency to improve single leg stance time by nearly 30% (NS), we did not observe any significant balance effects. In light of the very brief nature of the intervention sessions and the small number of weekly exposures, a maintenance effect for some bone sites was somewhat unexpected. Few differences were apparent between low-and higher intensity vibration maintenance effects on bone; however, HWBV seemed to improve static muscle endurance (wall squat) to a somewhat greater extent than LWBV. Effects were largely uninfluenced by age, height, weight, initial bone mass, current physical activity, dietary calcium, or compliance. Although our between-group differences were not significance, our within-group observations suggest that there may be subtle fracture risk benefits to be gained from even very modest engagement in WBV for postmenopausal women. The reduction in loss of bone at loaded sites combined with improved muscle function in squatting activities may reduce both risk of falling and risk of fracture should a fall occur. A tendency for a greater number of falls in the control group than either vibration group provides preliminary (but underpowered) support for a protective effect on falls. Increased exposure to WBV may confer more substantial benefits and warrants further examination.
FIGURE 4 Eight-mo within-group percent change (mean Ϯ SE) in muscle and balance measures after brief, twice-weekly whole body vibration; per protocol analysis (n ϭ 42). HWBV, higher intensity whole body vibration; LWBV, low-intensity whole body vibration; WS
Limitations
The contribution of bone geometry to bone strength is well known. Bone geometry is best evaluated using three-dimensional technology, such as magnetic resonance imaging or computed tomography. Because logistics prevented the latter measures in the current trial, we calculated an index of bone geometry and cross-sectional moment of inertia from DXA measures by using the methods developed and validated by Sievanen et al. 15 We recognize that this method limits our ability to directly detect an influence of the intervention on bone geometry. Bone marker data would have also assisted us to observe the effect of vibration on bone remodeling. Furthermore, it is acknowledged that nonequivalent WBV stimuli were applied in the LWBV and HWBV groups. As previously described, the justification for the approach was the desire to examine real-life manufacturers' recommended protocols and reflect the different theoretical mechanisms of action, namely direct vs. indirect (muscular) stimulation of bone. It is also noteworthy that despite adjusting for multiple comparisons in the analyses, subject numbers limited the statistical power of some comparisons. Large standard deviations created a risk of beta error, that is, a potential inability to detect a significant difference ( Table 3) .
As current therapeutic drug efficacy for osteoporotic fracture is limited by side effects, poor compliance, and lack of neuromuscular efficacy, there is a strong imperative to identify alternative preventive options. Twice-weekly treatment of either 15 mins of LWBV or 6 mins of HWBV is a minor treatment impost, as evidenced by the excellent study compliance by our subjects.
It is important to reemphasize that marked variation in stimulus intensities exist between the large range of WBV devices that exist in the commercial market. This dissimilarity limits the universal applicability of data collected from one WBV device to any other. In many cases, stimulus intensity of a device is not readily apparent. For this reason, efficacy and safety of a majority of WBV devices remain largely unknown. No side effects from either form of WBV were reported in our trial; however, one subject in the HWBV group (FN Tscore, Ϫ3.5) experienced a week of pain followed by a low trauma pelvic fracture 4 wks after initiating the intervention. Because the subject had sustained a low trauma pelvic fracture in the year before enrolling in the study, her physician concluded that the second fracture was not directly related to the intervention. It is unknown whether the HWBV stimulus contributed to the progression of the injury.
In conclusion, 8 mos of brief, twice-weekly WBV, for either 15 mins at 0.3 g vertical acceleration (30 Hz) or 6 mins at 1 g alternating limb acceleration (12.5 Hz) did not elicit detectable treatment effects in postmenopausal bone, muscle, or balance measures. However, within groups, WBV was associated with maintenance of bone at some clinically relevant sites (proximal femur and LS) and improvements in lower limb muscle function. HWBV, higher intensity whole body vibration; LWBV, low intensity whole body vibration; BMI, body mass index; WB, whole body; FN, femoral neck; TR, trochanter; LS, lumbar spine; PFA, proximal forearm; DFA, distal forearm; BUA, broadband ultrasound attenuation; BMC, bone mineral content; BMD, bone mineral density; CSMI, cross-sectional moment of inertia; D, dominant leg; ND, nondominant leg; SLS, single leg stance.
